Z-0476-2019 Class II Terminated

Recalled by Ortho-Clinical Diagnostics — Rochester, NY

FDA device recall Z-0476-2019 was initiated by Ortho-Clinical Diagnostics on Oct 8, 2018 and is designated Class II. Reason for recall: VITROS Chemistry Products dLDL Reagent GENs 26 and 27, negatively biased results The recall status is terminated (terminated Oct 13, 2022). Affected quantity: 5850 units.

Recall Details

Product Type
Devices
Report Date
Nov 28, 2018
Initiation Date
Oct 8, 2018
Termination Date
Oct 13, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5850 units

Product Description

VITROS¿ Chemistry Products dLDL Reagent-GENs 26 & 27. In Vitro Diagnostic to quantitatively measure LDL Cholesterol (LDLC) Product Code: 6801728 UDI (10758750006793)

Reason for Recall

VITROS Chemistry Products dLDL Reagent GENs 26 and 27, negatively biased results

Distribution Pattern

Nationwide Foreign: Australia Belgium Bermuda, HM11 Brazil Canada L3R 4G5 Chile China Colombia Denmark France Germany India Italy Japan Mexico Norway Poland Portugal Russia Singapore Spain Sweden The Netherlands United Kingdom

Code Information

Lot Numbers: 1517-26-6396 (expires 6-Nov-2018) 1517-26-6582 (expires 2-Feb-2019) 1517-26-6639 (expires 2-Feb-2019) 1517-27-6808 (expires 7-May-2019)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0476-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.